Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer: A European organization for research and treatment of cancer breast cancer cooperative group study

被引:35
作者
Clahsen, PC
vandeVelde, CJH
Julien, JP
Floiras, JL
Delozier, T
Mignolet, FY
Sahmoud, TM
机构
[1] UNIV LEIDEN HOSP, DEPT SURG, 2300 RC LEIDEN, NETHERLANDS
[2] EUROPEAN ORG RES TREATMENT CANC, CTR DATA, BRUSSELS, BELGIUM
[3] CTR HENRI BECQUEREL, F-76038 ROUEN, FRANCE
[4] CTR RENE HUGUENIN, ST CLOUD, FRANCE
[5] CTR FRANCOIS BACLESSE, F-14021 CAEN, FRANCE
关键词
D O I
10.1200/JCO.1996.14.3.745
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate whether a short intensive course of perioperative polychemotherapy can change the course of early breast cancer. Patients and Methods: A total of 2,795 women with early breast cancer, stage I to IIIA, were randomized onto a trial (European Organization for Research and Treatment of Cancer [EORTC] 10854) to compare surgery followed by one course of perioperative chemotherapy versus surgery alone. Patients assigned to the chemotherapy arm received one course of fluorouracil 600 mg/m(2), doxorubicin 50 mg/m(2), and cyclophosphamide 600 mg/m(2) (FAG) intravenously, within 24 hours after surgery. In both randomized treatment arms, a recommendation was made for premenopausal women with positive axillary nodes to receive prolonged courses of cyclophosphamide, methotrexate, and fluorouracil (CMF), according to the standard treatment for this subgroup. Results: At a median follow-up time of 41 months, local control was significantly better in the perioperative treatment arm as compared with the observation arm (hazards ratio, 0.60; 95% confidence interval, 0.44 to 0.83; P < .01). Disease-free survival was significantly prolonged in the chemotherapy arm (hazards ratio, 0.84; 95% confidence interval, 0.70 to 0.99; P = .04). Premenopausa node-negative patients especially showed an advantage for the perioperative chemotherapy arm. No advantage for perioperative chemotherapy was observed in premenopausal node-positive women who also had received prolonged chemotherapy. Conclusion: We conclude that one course of perioperative FAC is able to improve local control and can prolong disease-free survival in women with early breast cancer. However, our results also suggest that a perioperative timing cannot improve the results of standard prolonged chemotherapy in premenopausal women with positive axillary nodes.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 39 条
  • [1] ABE O, 1992, LANCET, V339, P71
  • [2] [Anonymous], 1992, Lancet, V339, P1
  • [3] RESULTS OF THE CANCER-RESEARCH CAMPAIGN ADJUVANT TRIAL FOR PERIOPERATIVE CYCLOPHOSPHAMIDE AND LONG-TERM TAMOXIFEN IN EARLY BREAST-CANCER REPORTED AT THE 10TH YEAR OF FOLLOW-UP
    BAUM, M
    HOUGHTON, J
    RILEY, D
    MACINTYRE, J
    BERSTOCK, D
    MCKINNA, A
    JACKSON, I
    SAINSBURY, JRC
    WILSON, A
    WHEELER, T
    DOBBS, J
    REES, G
    POWLES, T
    RUBENS, R
    HAYBRITTLE, J
    MCPHERSON, K
    HOUGHTON, J
    [J]. ACTA ONCOLOGICA, 1992, 31 (02) : 251 - 257
  • [4] ADJUVANT CHEMOTHERAPY IN NODE-NEGATIVE BREAST-CANCER NCI CONSENSUS CONFERENCE
    BONADONNA, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (07) : 844 - 845
  • [5] THROMBOEMBOLIC COMPLICATIONS AFTER PERIOPERATIVE CHEMOTHERAPY IN WOMEN WITH EARLY BREAST-CANCER - A EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER BREAST-CANCER COOPERATIVE GROUP-STUDY
    CLAHSEN, PC
    VANDEVELDE, CJH
    JULIEN, JP
    FLOIRAS, JL
    MIGNOLET, FY
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1266 - 1271
  • [6] COX DR, 1972, J R STAT SOC B, V34, P187
  • [7] *EORTC, 1991, EORTC MONOGRAPH
  • [8] FISHER B, 1975, SURG GYNECOL OBSTET, V140, P528
  • [9] FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765
  • [10] FISHER B, 1989, CANCER RES, V49, P1996